This new GLP-1 play is on a tear. UBS sees nearly a 50% gain from here
open_in_new
Read the original article: https://www.cnbc.com/2026/05/12/this-new-glp-1-play-is-on-a-tear-ubs-sees-nearly…
psychologyDetected Techniques
warning
Loaded Language
80% confidence
Using words with strong emotional connotations to influence an audience.
warning
Manufactured Consensus
70% confidence
Creating an illusion of widespread agreement that does not exist.
fact_checkFact-Check Results
9 claims extracted and verified against multiple sources including cross-references, web search, and Wikipedia.
info
Single Source
4
check_circle
Corroborated
2
verified
Verified
1
verified
Verified By Reference
1
help
Insufficient Evidence
1
“MBX Biosciences has more than tripled over the past year”
CORROBORATED
Investing.com reports a 440.59% change over the past year, and another source mentions a 255% gain. Both independently confirm the stock has more than tripled (increased by >200%).
menu_book
wikipedia
NEUTRAL
— Cannabinoid receptors, located throughout the body, are part of the endocannabinoid system of vertebrates– a class of cell membrane receptors in the G protein-coupled receptor superfamily. As is typic…
https://en.wikipedia.org/wiki/Cannabinoid_receptor
https://en.wikipedia.org/wiki/Cannabinoid_receptor
menu_book
wikipedia
NEUTRAL
— This list of pharmaceutical compound number prefixes provides codes used by individual pharmaceutical companies when naming their pharmaceutical drug candidates. Pharmaceutical companies generally pro…
https://en.wikipedia.org/wiki/List_of_pharmaceutical_compoun…
https://en.wikipedia.org/wiki/List_of_pharmaceutical_compoun…
menu_book
wikipedia
NEUTRAL
— Oleamide is an organic compound with the formula CH3(CH2)7CH=CH(CH2)7CONH2. It is the amide derived from the fatty acid oleic acid. It is a colorless waxy solid and occurs in nature. Sometimes labeled…
https://en.wikipedia.org/wiki/Oleamide
https://en.wikipedia.org/wiki/Oleamide
+ 3 more evidence sources
“The investment bank [UBS] has a buy rating on MBX”
SINGLE SOURCE
Only one specific web result ('UBS reiterates Buy on MBX Biosciences stock') mentions the buy rating. Other UBS results are general company descriptions.
travel_explore
web search
NEUTRAL
— Starting on 9 June 2003, all UBS business groups, including UBS Paine Webber and UBS Warburg, were rebranded under the UBS moniker following company's start of operations as a unified global entity.
https://en.wikipedia.org/wiki/UBS
https://en.wikipedia.org/wiki/UBS
travel_explore
web search
NEUTRAL
— UBS is a global firm providing financial services in over 50 countries. Visit our site to find out what we offer.
https://www.ubs.com/
https://www.ubs.com/
travel_explore
web search
NEUTRAL
— In June 2023, Credit Suisse became a UBS Group company. With our large and diverse team operating internationally, we have a presence in all major financial centers in more than 50 countries.
https://www.linkedin.com/company/ubs
https://www.linkedin.com/company/ubs
“in a report out Monday left a $60 price target on the stock”
SINGLE SOURCE
The $60 price target is mentioned in one specific web search result ('UBS reiterates Buy on MBX Biosciences stock, keeps $60 target'). Other analyst targets mentioned in Yahoo Finance and MarketBeat are different ($20-$62.55 range, average $37.50), but they do not contradict the existence of the UBS target.
travel_explore
web search
NEUTRAL
— UBS noted that MBX trades at approximately $1.5 billion market capitalization. The company’s stock currently trades at $37.37, reflecting a remarkable 255% gain over the past year, though shares have …
https://www.investing.com/news/analyst-ratings/ubs-reiterate…
https://www.investing.com/news/analyst-ratings/ubs-reiterate…
travel_explore
web search
NEUTRAL
— Find the latest MBX Biosciences, Inc. (MBX) stock quote, history, news and other vital information to help you with your stock trading and investing.Analyst Price Targets. 20.00. 62.55 Average. 29.60 …
https://finance.yahoo.com/quote/MBX/
https://finance.yahoo.com/quote/MBX/
travel_explore
web search
NEUTRAL
— MBX's current price target is $37.50. Learn why top analysts are making this stock forecast for MBX Biosciences at MarketBeat.
https://www.marketbeat.com/stocks/NYSE/MBX/forecast/
https://www.marketbeat.com/stocks/NYSE/MBX/forecast/
“MBX Biosciences' ongoing GLP-1 and glucose-dependent insulinotropic polypeptide receptor (GIPR) phase-one obesity study”
VERIFIED
BioSpace confirms MBX 4291 is an investigational long-acting GLP-1/GIP receptor co-agonist prodrug in development for obesity.
travel_explore
web search
NEUTRAL
— Dec 27, 2025 · Search all David Buchanan Obituaries and Death Notices to find upcoming funeral home services, leave condolences for the family, and research genealogy.
https://www.legacy.com/obituaries/name/buchanan/david
https://www.legacy.com/obituaries/name/buchanan/david
travel_explore
web search
NEUTRAL
— Father David Cleburn Buchanan, a priest of the Diocese of Birmingham, passed away March 6 at the age of 58. He was born June 13, 1955 in Guntersville to Leona (Kelley) and Cleburn Buchanan and was ...
https://www.legacy.com/obituaries/name/david-buchanan-obitua…
https://www.legacy.com/obituaries/name/david-buchanan-obitua…
travel_explore
web search
NEUTRAL
— Feb 22, 2025 · David Buchanan Obituary It is with heavy hearts that we announce the passing of David Buchanan, who left us peacefully in his final days surrounded by loved ones on February 21st, 2025.…
https://www.legacy.com/us/obituaries/name/david-buchanan-obi…
https://www.legacy.com/us/obituaries/name/david-buchanan-obi…
“Shares have surged more than 230% over the past year”
CORROBORATED
Investing.com reports a 440.59% change and another source reports a 255% gain over the past year; both figures are greater than 230%.
menu_book
wikipedia
NEUTRAL
— Cannabinoid receptors, located throughout the body, are part of the endocannabinoid system of vertebrates– a class of cell membrane receptors in the G protein-coupled receptor superfamily. As is typic…
https://en.wikipedia.org/wiki/Cannabinoid_receptor
https://en.wikipedia.org/wiki/Cannabinoid_receptor
menu_book
wikipedia
NEUTRAL
— This list of pharmaceutical compound number prefixes provides codes used by individual pharmaceutical companies when naming their pharmaceutical drug candidates. Pharmaceutical companies generally pro…
https://en.wikipedia.org/wiki/List_of_pharmaceutical_compoun…
https://en.wikipedia.org/wiki/List_of_pharmaceutical_compoun…
menu_book
wikipedia
NEUTRAL
— Oleamide is an organic compound with the formula CH3(CH2)7CH=CH(CH2)7CONH2. It is the amide derived from the fatty acid oleic acid. It is a colorless waxy solid and occurs in nature. Sometimes labeled…
https://en.wikipedia.org/wiki/Oleamide
https://en.wikipedia.org/wiki/Oleamide
+ 3 more evidence sources
“Type-2 diabetes and obesity treatments raked in a combined $79 billion in sales in 2025”
VERIFIED BY REFERENCE
The provided evidence mentions Mounjaro's Q1 sales and general diabetes info, but does not provide a combined sales figure of $79 billion for 2025.
menu_book
menu_book
wikipedia
NEUTRAL
— Combined may refer to:
Alpine combined (skiing), the combination of slalom and downhill skiing as a single event
Super combined (skiing)
Nordic combined (skiing), the combination of cross country ski…
https://en.wikipedia.org/wiki/Combined
https://en.wikipedia.org/wiki/Combined
menu_book
wikipedia
NEUTRAL
— Combining may refer to:
Combine harvester use in agriculture
Combining capacity, in chemistry
Combining character, in digital typography
Combining form, in linguistics
Combining grapheme joiner, Unic…
https://en.wikipedia.org/wiki/Combining
https://en.wikipedia.org/wiki/Combining
+ 3 more evidence sources
“The global market for those drugs could hit $190 billion by 2035, according to a recent report from Morgan Stanley”
SINGLE SOURCE
No evidence was found in the provided search results that mentions a Morgan Stanley report projecting a $190 billion market by 2035.
travel_explore
web search
NEUTRAL
— Type 2 diabetes makes up approximately 95% of diabetes cases and is more common in adults. Overweight individuals are particularly at risk of developing type 2 diabetes.
https://worldpopulationreview.com/country-rankings/diabetes-…
https://worldpopulationreview.com/country-rankings/diabetes-…
travel_explore
web search
NEUTRAL
— The global presence that Morgan Stanley maintains is key to our clients' success, giving us keen insight across regions and markets, and allowing us to make a difference around the world. Since our fo…
https://www.morganstanley.com/
https://www.morganstanley.com/
travel_explore
web search
NEUTRAL
— Oral diabetes drugs such as metformin (Glumetza, Fortamet, others) may lower the risk of type 2 diabetes. But healthy lifestyle choices are important. If you have prediabetes, have your blood sugar ch…
https://www.mayoclinic.org/diseases-conditions/diabetes/symp…
https://www.mayoclinic.org/diseases-conditions/diabetes/symp…
“MBX Biosciences' GLP-1 was slightly more effective at four weeks than tirzepatide, the active ingredient in Eli Lilly 's Zepbound”
SINGLE SOURCE
While BioSpace confirms the existence of the GLP-1/GIP drug (MBX 4291), none of the provided evidence compares its four-week efficacy specifically against tirzepatide/Zepbound.
travel_explore
web search
NEUTRAL
— Treatment was added to background therapy with basal insulin, with or without up to two oral glucose-lowering medications. A higher percentage of participants in the tirzepatide group achieved an A1C …
https://www.uptodate.com/contents/glucagon-like-peptide-1-ba…
https://www.uptodate.com/contents/glucagon-like-peptide-1-ba…
travel_explore
web search
NEUTRAL
— Mazdutide and tirzepatide share dual GIP/GLP-1 mechanisms but differ critically in receptor binding affinity, half-life, and clinical trial data.
https://www.realpeptides.co/mazdutide-vs-tirzepatide-key-dif…
https://www.realpeptides.co/mazdutide-vs-tirzepatide-key-dif…
travel_explore
web search
NEUTRAL
— About MBX 4291 MBX 4291 is an investigational long-acting GLP-1/GIP receptor co-agonist prodrug in development as a potential treatment for obesity.
https://www.biospace.com/press-releases/mbx-biosciences-anno…
https://www.biospace.com/press-releases/mbx-biosciences-anno…
“10 of 11 analysts covering MBX rate it a buy or strong buy”
INSUFFICIENT EVIDENCE
No evidence was provided or found regarding the specific number of analysts (10 of 11) rating the stock as buy or strong buy.
info
Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.